Subtle clues—from handwriting to snoring—can reveal the earliest warnings of illness. Here's how to read your own distress ...

Infliximab biosimilar is under clinical development by Celltrion and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

NO festive gathering is complete without a feast, desserts and plenty of holiday drinks. But while these celebrations are exciting, they can be hard on our stomachs, often leading to that familiar ...

Divine Gol n Win best win percentage cricket captain Takeda's Entyvio SC achieves success in Phase III clinical tri ...